Stock listing

Theralase Technologies Inc.

Selected listing: A0DLB7 · LS · EUR · DE

Theralase Technologies Inc. (Lang & Schwarz: A0DLB7), Health Technology. Latest release Sep 18, 2026: Correcting and Replacing: Theralase(R) Releases Q2 2026…

A0DLB7:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A0DLB7
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Theralase Technologies Inc.

Correcting and Replacing: Theralase(R) Releases Q2 2026 Financial Statements

September 18, 2026

Theralase(R) Commences GLP Toxicology Analysis of Rutherrin(R)

September 15, 2026

Theralase(R) Releases Q2 2026 Financial Statements

August 28, 2026

Theralase(R) Closes C$3.6 Million Brokered Financing

August 24, 2026

Theralase(R) Announces $5 Million Brokered LIFE Offering

August 10, 2026

All Theralase Technologies Inc. news →

Research Theralase Technologies Inc.

Theralase Technologies Inc. company profile

View the public company page for Theralase Technologies Inc. on 6ix.

Theralase Technologies Inc. news

Read company news and market updates connected to Theralase Technologies Inc..

Theralase Technologies Inc. investor events

Find investor webinars, events, and replay context for Theralase Technologies Inc..